Paper
0
ALL-410 In-depth Responder Analysis of PhALLCON, a Phase 3 Trial of Ponatinib Versus Imatinib in Newly Diagnosed Ph+ ALL
Authors
Elias Jabbour,Hagop Kantarjian
Ibrahim Aldoss,Pau Montesinos,Jessica Leonard,David Gómez‐Almaguer,Maria Baer,Carlo Gambacorti‐Passerini,James McCloskey,Yosuke Minami,Cristina Papayannidis,Philippe Rousselot,Pankit Vachhani,Eunice Wang,Lin Yang,Meliessa Hennessy,Alexander Vorog,Niti Patel
+16 authors
,Jose-Maria Ribera-SantasusanaPublished
Sep 1, 2024
Show more
Save
Tip0
TipSave